Equity markets in India and the US: Sensex, Nifty, Wall Street indices, IPOs and the corporate news that moves stocks.
Investor enthusiasm surged on the final day of the National Stock Exchange's landmark IPO, with qualified institutional buyers oversubscribing their segment by ...
With regulatory approvals set to expire by the end of September, nearly twenty-four companies are racing against the clock to launch their initial public offeri...

The Indian steel sector has grown production at the fastest pace globally this calendar year (CY), and also post Covid, between CY22 and CY25. Large steel players, like Tata Steel and JSW Steel have ramped up production capacity aggressively over the past few years, and helped India achieve the above trend. However, SAIL trades at a discount of 23% to 42% to larger peers.
US stocks are climbing with markets worldwide after oil prices and yields in the bond market gave back some of their jumps from last week.
India Business News: The $2.3 billion initial public offering of the National Stock Exchange of India (NSE) was subscribed 5.7 times by the end of the final day...

The initial public offering (IPO) of the National Stock Exchange of India (NSE) closed for subscription on September 21 with the issue receiving a strong response from institutional investors, while the retail portion was subscribed 1.35 times.

Technically, Nifty’s move back above 23,400 is encouraging following the recent correction and provides some near-term relief, said an analyst

Sensex, Nity also took a cue from strong global cues, helped by gains in semiconductor stocks.

The JPMorgan chief executive officer is scheduled to attend an annual investment conference hosted by the firm in Mumbai, where he will meet executives from India’s top conglomerates

Moneyview IPO GMP today. Find out Moneyview IPO grey market premium, kostak, subject to sauda rates with expected listing gain.
Sensex today: Analysts at SBI Securities said that the gradual decline in crude oil prices over the last four trading sessions has provided some respite to Asian equities.

The rally followed a U.S.-Denmark-Greenland security pact aimed at expanding the military presence on the Arctic territory.

Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
MSCIs Asia Pacific equities gauge advanced 0.2% with Japan shut for a public holiday. S&P 500 futures rose 0.3% after the underlying gauge eked out a gain Frida...
(MENAFN - GlobeNewsWire - Nasdaq) PARMA, Italy, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LiTime, a global LiFePO4 power solutions expert, showcased its new 12V 320Ah ComFlex Smart LiFePO4 Battery As ...

WALNUT CREEK, Calif.--(BUSINESS WIRE)---- $CENT #CentralToHome--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a leading consumer goods company in the pet and garden industries, today announced a planned leadership transition for its Garden segment. J.D. Walker, President, Garden Consumer Products, will retire from that role effective September 26, 2026, at which point Jason Barnes, Executive Vice President, Garden Consumer Products, will assume responsibility for sales

CVRX, Inc. (NASDAQ: CVRX) ("CVRX"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that John Landry has been appointed Chief Financial Officer, succeed...

Australia's Firmus to launch $7 billion IPO on October 6

Company Presentation to Be Broadcast Virtually at 11 am ET on Thursday, September 24, 2026 GEORGETOWN, TX / ACCESS Newswire / September 21, 2026 / TSS, Inc. (Nasdaq:TSSI), a data center services co...

SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that Eric Dube, Ph.D., has made the difficult and personal decision to step down as president and chief executive officer to focus on his health and family. The Company’s Board of Directors has unanimously appointed Bradley L. Campbell, former president and CEO of Amicus Therapeutics, now a wholly owned subsidiary of BioMarin Pharmaceutical Inc., to succeed Dr. Dube as president and chief executive of
Each story below is a short excerpt from reporting by an established publisher, shown in the publisher's own words. We credit the publisher and link to the original article. Stories are matched to this topic by keyword and shown newest first.